The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Sign up for our newsletter to get the latest on the transformative ...
- Tremendous activity in recent months, including receipt of Japanese marketing approval, the fifth parallel U.S. trial approval, data from pancreatic cancer trials presented at ASCO GI Symposium, and ...
View original content to download multimedia:https://www.prnewswire.com/news-releases/alpha-announces-financial-results-for-fourth-quarter-and-full-year-2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results